Antibodies Assay Kits Biology Cells Brd4 Antibody Muc2 Antibody NATtrol Nedd4 Antibody Nox1 Antibody Panel Particles PCR Pcr Kits Peptides Vector & Virus Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
Metabolic sample reconstruction is a vital think about tumor development. Metabolism of tumor cells is characterised by irregular enhance in anaerobic glycolysis, no matter excessive oxygen focus, leading to a major accumulation of power from glucose sources.
These adjustments promotes speedy cell proliferation and tumor development, which is additional referenced a course of generally known as the Warburg impact. The present examine reconstructed the metabolic sample in development of most cancers to determine genetic adjustments particular in most cancers cells. A complete of 12 widespread kinds of stable tumors have been included within the present examine.
Gene set enrichment evaluation (GSEA) was carried out to research 9 glycolysis-related gene units, that are implicated within the glycolysis course of. Univariate and multivariate analyses have been used to determine unbiased prognostic variables for building of a nomogram based mostly on clinicopathological traits and a glycolysis-related gene prognostic index (GRGPI).
The prognostic mannequin based mostly on glycolysis genes confirmed excessive space beneath the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the present examine confirmed that eight genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) have been correlated with total survival (OS) and recurrence-free survival (RFS).
Additional evaluation confirmed that the prediction mannequin precisely distinguished between high- and low-risk most cancers sufferers amongst sufferers in several clusters in LIHC. A nomogram with a well-fitted calibration curve based mostly on gene expression profiles and medical traits confirmed good discrimination based mostly on inner and exterior cohorts. These findings point out that adjustments in expression degree of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.
Modifications in Methylation Patterns of Tumor Suppressor Genes throughout Prolonged Human Embryonic Stem Cell Cultures
Whereas research on embryonic stem cells have been actively carried out, little is understood in regards to the epigenetic mechanisms in human embryonic stem cells (hESCs) in prolonged tradition methods. Right here, we investigated whether or not CpG island (CGI) methylation patterns of 24 tumor suppressor genes could possibly be maintained throughout prolonged hESC cultures. In complete, 10 hESC strains have been analyzed.
For every cell line, genomic DNA was extracted from early and late passages of cell cultures. CGI methylation ranges of 24 tumor suppressor genes have been analyzed utilizing methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), pyrosequencing, and real-time polymerase chain response (PCR). Totally different CGI methylation patterns of CASP8, FHIT, and CHFR genes have been recognized in between early and late passages in some hESC strains.
CGI methylation ranges of CASP8 considerably elevated at late passage in CHA-36, CHA-40, and CHA-42 cell strains in comparison with these at early passage. The CGI methylation of the FHIT gene was greater at late passage than at early passage in CHA-15, CHA-31, CHA-32, and iPS (FS)-1 cell strains however decreased on the late passage in CHA-20 and H1 cell strains.
Totally different CGI methylation patterns have been detected for the CHFR gene solely in iPS (FS)-1, and the extent considerably elevated at late passage. Thus, our findings present that CGI methylation patterns could possibly be altered throughout extended ESC cultures and analyzing these epigenetic adjustments is vital to evaluate the upkeep, differentiation, and medical utilization of stem cells.
A genetic danger rating utilizing human chromosomal-scale size variation can predict schizophrenia
Research point out that schizophrenia has a genetic part, nevertheless it can’t be remoted to a single gene. We aimed to find out how nicely one might predict that an individual will develop schizophrenia based mostly on their germ line genetics. We in contrast 1129 folks from the UK Biobank dataset who had a prognosis of schizophrenia to an equal variety of age matched folks drawn from the overall UK Biobank inhabitants.
For every particular person, we constructed a profile consisting of numbers. Every quantity characterised the size of segments of chromosomes. We examined a number of machine studying algorithms to find out which was simplest in predicting schizophrenia and if any enchancment in prediction happens by breaking the chromosomes into smaller chunks.
We discovered that the stacked ensemble, carried out greatest with an space beneath the receiver working attribute curve (AUC) of 0.545 (95% CI 0.539-0.550). We famous a rise within the AUC by breaking the chromosomes into smaller chunks for evaluation. Utilizing SHAP values, we recognized the X chromosome as a very powerful contributor to the predictive mannequin. We conclude that germ line chromosomal scale size variation knowledge might present an efficient genetic danger rating for schizophrenia which performs higher than probability.
Clinically important findings of high-risk mutations in human SLC29A4 gene related to diabetes mellitus kind 2 in Pakistani inhabitants
This examine carried out an in-depth evaluation combining computational and experimental verifications of the deleterious missense mutations related to the SLC29A4 protein. The purposeful annotation of the non-synonymous single nucleotide polymorphism (nsSNPs), adopted by structure-function evaluation, revealed 13 single nucleotide polymorphisms (SNP) as probably the most damaging.
Amongst these, six mutants P429T/S, L144S, M108V, N86H, and V79E, have been predicted as structurally and functionally damaging by protein stability evaluation. Additionally, these variants are situated at evolutionary conserved areas, both buried, contributing to the structural injury, or uncovered, inflicting purposeful adjustments within the protein.
These mutants have been additional taken for molecular docking research. When verified by way of experimental evaluation, the SNPs M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) confirmed an affiliation with kind 2 diabetes mellitus (T2DM). Minor allele frequency for rs149798710 (A > G) was 0.23 in controls, 0.29 in metformin responders, 0.37 in metformin non-responder, for rs151039853 (A > C) was 0.21 in controls, 0.28 in metformin responders, 0.36 in metformin non-responder and for rs17854505 (T > A) was 0.20 in controls, 0.25 in metformin responders, 0.37 in metformin non-responder.
Recombinant Genome polyprotein |
|||
| MBS1141323-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 640 |
Recombinant Genome polyprotein |
|||
| MBS1141323-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 695 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 620 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 795 |
Recombinant Genome polyprotein |
|||
| MBS1040920-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 720 |
Recombinant Genome polyprotein |
|||
| MBS1040920-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 930 |
Recombinant JEV Genome polyprotein (aa 2528-3432) Protein |
|||
| VAng-Wyb3447-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 9926.4 |
|
Description: Japanese encephalitis virus (strain Jaoars982) Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3657.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1083.6 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3408 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2452.8 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1693.2 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant human Genome polyprotein |
|||
| MBS960928-005mg | MyBiosource | 0.05mg | EUR 695 |
Recombinant human Genome polyprotein |
|||
| MBS960928-02mg | MyBiosource | 0.2mg | EUR 905 |
Recombinant human Genome polyprotein |
|||
| MBS960928-05mg | MyBiosource | 0.5mg | EUR 990 |
Recombinant human Genome polyprotein |
|||
| MBS960928-1mg | MyBiosource | 1mg | EUR 1355 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-01mg | MyBiosource | 0.1mg | EUR 410 |
Recombinant HCV Genome polyprotein protein, N- GST Tag |
|||
| MBS157516-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Genome polyprotein, partial |
|||
| MBS1014881-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Genome polyprotein, partial |
|||
| MBS1088414-INQUIRE | MyBiosource | INQUIRE | Ask for price |
OPCA05394-20UG - GENOME POLYPROTEIN Recombinant Protein (isolate 1) |
|||
| OPCA05394-20UG | Aviva Systems Biology | 20ug | EUR 339 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant CSFV Genome polyprotein protein, N-His Tag |
|||
| MBS156846-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
|||
| VAng-Cr6545-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
|||
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156947-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, No Tag |
|||
| MBS156948-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba | Cusabio | 5430 mg | Ask for price |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba-20ug | Cusabio | 20ug | Ask for price |
|
Description: 1-631aa |
|||
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Echovirus 16 Genome polyprotein |
|||
| MBS1346831-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Echovirus 11 Genome polyprotein |
|||
| MBS1164799-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS1133753-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1369865-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 6 Genome polyprotein |
|||
| MBS1393297-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 12 Genome polyprotein |
|||
| MBS1285198-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 1 Genome polyprotein |
|||
| MBS1036392-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Echovirus 9 Genome polyprotein |
|||
| MBS1461867-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Echovirus 30 Genome polyprotein |
|||
| MBS1479634-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-002mg | MyBiosource | 0.02mg | EUR 1845 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-01mg | MyBiosource | 0.1mg | EUR 2775 |
Recombinant Langat virus Genome polyprotein |
|||
| MBS7038287-5x01mg | MyBiosource | 5x0.1mg | EUR 12450 |
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-100ug | Biomatik Corporation | 100ug | EUR 721.6 |
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157116-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS157181-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Senecavirus A Genome polyprotein protein, C-His Tag |
|||
| MBS1562943-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 880 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 500 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 700 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 655 |
Recombinant Echo 9 virus Genome polyprotein |
|||
| MBS1066973-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 700 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Enterovirus A71 Genome polyprotein protein, N-His Tag |
|||
| MBS157180-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1166653-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Coxsackievirus B6 Genome polyprotein |
|||
| MBS1374038-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Coxsackievirus A9 Genome polyprotein |
|||
| MBS1261214-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1424493-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1424493-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1424493-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1424493-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1424493-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Coxsackievirus B3 Genome polyprotein |
|||
| MBS1106207-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1210 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Coxsackievirus B1 Genome polyprotein |
|||
| MBS1049458-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Coxsackievirus B4 Genome polyprotein |
|||
| MBS1455843-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1125 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 1000 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Coxsackievirus B2 Genome polyprotein |
|||
| MBS1480288-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1230 |
Recombinant Coxsackievirus A21 Genome polyprotein |
|||
| MBS1237637-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Coxsackievirus A21 Genome polyprotein |
|||
| MBS1237637-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Recombinant Coxsackievirus A21 Genome polyprotein |
|||
| MBS1237637-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1005 |
Recombinant Coxsackievirus A21 Genome polyprotein |
|||
| MBS1237637-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1045 |
Recombinant Coxsackievirus A21 Genome polyprotein |
|||
| MBS1237637-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1145 |
Recombinant Bovine enterovirus Genome polyprotein |
|||
| MBS1237279-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1195 |
Recombinant Bovine enterovirus Genome polyprotein |
|||
| MBS1237279-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 845 |
Recombinant Bovine enterovirus Genome polyprotein |
|||
| MBS1237279-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 985 |
Recombinant Bovine enterovirus Genome polyprotein |
|||
| MBS1237279-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1015 |
Recombinant Bovine enterovirus Genome polyprotein |
|||
| MBS1237279-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1120 |
Recombinant Coxsackievirus A16 Genome polyprotein |
|||
| MBS1364023-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1200 |
Recombinant Coxsackievirus A16 Genome polyprotein |
|||
| MBS1364023-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 850 |
Recombinant Coxsackievirus A16 Genome polyprotein |
|||
| MBS1364023-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 990 |
Recombinant Coxsackievirus A16 Genome polyprotein |
|||
| MBS1364023-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1020 |
Recombinant Coxsackievirus A16 Genome polyprotein |
|||
| MBS1364023-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1125 |
Recombinant Coxsackievirus A24 Genome polyprotein |
|||
| MBS1064850-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1215 |
Recombinant Coxsackievirus A24 Genome polyprotein |
|||
| MBS1064850-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 870 |
Therefore, this examine concludes that SLC29A4 M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) polymorphisms have been related to the elevated danger of T2DM in addition to with the elevated danger in direction of the failure of metformin therapeutic response in T2DM sufferers of Pakistan. Communicated by Ramaswamy H. Sarma.
